Short Interest in Prenetics Global Limited (NASDAQ:PRENW) Increases By 741.0%

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 14,634 shares, a growth of 741.0% from the February 12th total of 1,740 shares. Based on an average daily trading volume, of 14,529 shares, the short-interest ratio is currently 1.0 days. Based on an average daily trading volume, of 14,529 shares, the short-interest ratio is currently 1.0 days.

Prenetics Global Stock Performance

NASDAQ PRENW traded down $0.00 on Tuesday, reaching $0.02. The company’s stock had a trading volume of 39,260 shares, compared to its average volume of 19,729. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.07. The business has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.03.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.